Advocates of "Medicare for All" like Bernie Sanders underestimate the significant challenges to its implementation while ignoring or dismissing alternative models that achieve the same goal: equitable healthcare access for all.
Marathon Pharmaceuticals is doing some backtracking after the public, the media and now Bernie Sanders objected to the list price of its upcycled corticosteroid for Duchenne muscular dystrophy.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Bernie Sanders appeared on Real Time with Bill Maher to charge that Big Pharma spends more money on marketing and advertising than on research and development. Was he right?
A universal healthcare ballot measure is the latest in a series of cutting edge policy change proposals put in front of Colorado voters. But will it get the support of residents that recreational marijuana did?
The movement to save Lakewood Hospital outside Cleveland seems misguided.
Vermont Sen. Bernie Sanders released details of his "Medicare for all" single-payer healthcare proposal about two hours before the debate, perhaps fueling renewed interest in the Democratic race.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
How stressed does Hillary Clinton get when talking about Wall Street or gun control?
Also, a new song from ZDogg, Baidu is in trouble for its medical claims and LifeWatch gets a new FDA clearance.
Theranos founder Elizabeth Holmes has moved to limit its fingerprick blood test vials after being forced on the defensive over its technology claims.